Skip to content

Dortmund, 28th January 2025

“Overwhelming” – this is how Susmita Ghosh describes the feeling when she learnt that her grant application had been successful. Together with a cooperating partner, she has received 10,000 euros from the DFG Collaborative Research Centre TRR 332 »Neutrophils: Origin, Fate and Function« for her pilot project. The 28-year-old has been working as a doctoral student in the Biofluorescence research group since October 2021. The financial funding is the first grant of her career.

Under investigation: interaction between neutrophils and tumour cells

In her research, the biologist analyses proteins in neutrophil granulocytes. Neutrophils are a type of white blood cells and an important part of our immune system. However, in situations such as strokes, heart attacks or cancer, neutrophils can also turn against us and worsen our state of health. Ghosh wants to find out why that is the case. Her pilot project »Dissecting the neutrophil-tumor cell interactome using SILAC-labelling«, supported by TRR 332, will investigate how neutrophils and cancer cells interact. Ghosh submitted the grant application together with Dr Claudia Tulotta from the Institute of Experimental Pathology at the University of Münster. Of the financial support, 4,000 euros will go to Dortmund for Ghosh's research in the pilot project and 6,000 euros to Münster.

Susmita Ghosh at the ultrasensitive mass spectrometer.

Susmita Ghosh joined ISAS as a doctoral researcher in 2021. The then 25-year-old ventured from Kolkata (India) to Dortmund for her dissertation in the middle of the pandemic. She shares more about this in an interview on ISAS Kompakt.

© ISAS / Hannes Woidich

Ghosh would also like to thank her supervisors Prof Dr Albert Sickmann and Prof Dr Matthias Gunzer – “not only for their support, but also for their feedback on the project. I am absolutely convinced that criticism makes us better.” She sees her future in science. Another reason, why the funding is particularly important to her: “My goal is to lead a research group one day. The grant for this pilot project is a small but very important step on my career path.”

(Nadine Kuhnen / Sara Rebein)

Share

Further articles

Separating Fluorescence Signals Faster and More Precisely with AI

When different fluorescence signals overlap during microscopy, their clear assignment to specific biological structures becomes difficult. To address this common problem, Dr Davide Panzeri is developing AI-based signal separation methods. The biophysicist has been awarded a Marie Skłodowska-Curie Fellowship by the European Union for his promising research project.

Porträt Dr. Davide Panzeri.

Passionate Research, Shaping the Future

How do GRK5 inhibitors work at the cellular level and within the living organism? Biologist Dr Susanne Grund is working with her colleagues at HI-FIVE on a new therapeutic approach for heart failure. In this portrait, she describes what her day-to-day work looks like, balancing research on human stem cells with studies on mice.

ISAS BFF Uploader

What are you doing at ISAS, Theresa?

Why do mice undergo ultrasound examinations of their hearts? What does a typical working day in the lab involve for a technical assistant in the HI-FIVE research project ? And what challenges does the job present? Theresa Pietz provides fascinating insights into her duties, motivations and experiences working with animals.

Study with Heart: A Doctor Bridging Clinic & Laboratory

What is actually happening behind the scenes of a patient trial? Anna Ruzhyna is a clinical research associate who looks after participants with heart failure as part of the HI-FIVE project. She explains how her work helps to develop new therapeutic approaches for the treatment of heart failure.

Laboratory Meets Clinic: Understanding Heart Function with Stem Cells

How can new therapeutic approaches for heart failure be developed more effectively? Stem cell research plays a central role in the HI-FIVE project. In this interview, PD Dr Anna Klinke (Herz- und Diabeteszentrum NRW) talks about her work between the lab and the clinic. She explains how the versatility of stem cells enables heart and vascular cells to be obtained from individual patients' blood and why this is an important step in investigating the specific effects of new active substances.

What are you doing at ISAS, Kevin?

What changes take place in heart muscle cells when a left ventricular assist device is used? ISAS doctoral student Kevin Hau (28) is tackling this question by researching the consequences of heart attacks using various omics analyses.

Kevin Hau is wearing a white coat bearing the ISAS logo. He is standing next to a microscope in a laboratory. In the lower left corner of the image, a computer screen can be seen. Open on the monitor is a microscopic image of reddish tissue.

Copenhagen: Different Molecules, New Perspectives?

Felix Hormann is spending three months conducting research at the University of Copenhagen. In this interview, the ISAS doctoral student discusses the new perspective he has gained on his lipid research and his exciting day-to-day life as a scientist in Denmark.

Felix Hormann is standing at a crossroads. In the background, there is a traffic sign with writing in Danish.

New Perspectives for Heart Failure Therapy

How are new therapeutic approaches being developed to close the gap in the treatment of patients with heart failure? And what knowledge from clinical practice is crucial for this? Prof. Dr Tanja Rudolph provides insights into her daily work as a cardiologist and talks about her role in the translational research project HI-FIVE, and the future of cardiovascular disease therapy.